Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-26

Clinical Trial Update: Safety, Tolerability & Pharmacokinetics (PK) of Co-administered Single Doses of OZ439 and Mefloquine (MQ) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetics update for co-administered OZ439 and mefloquine in healthy volunteers. The study was terminated and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mefloquine (Mefloquine)
  • OZ439

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: TERMINATED | Results posted: 2015-03-26